Cyannopyrrolidine moiety interacts with S1, whereas hydroxy adamantyl interacts with the S2 subsite
That means you cannot legitimately place 10.8% for cagrilintide next to 24.2% for retatrutide and declare a winner, because those numbers come from different trials, different populations, different durations (26 vs 48 weeks), different doses, and critically a monotherapy figure for one versus a monotherapy figure for the other, while cagrilintides strongest data are actually as a combination
The Legal Hurdles: Why Injectable Hydroxocobalamin is a POM For patients, the legal classification of hydroxocobalamin often feels illogical and deeply frustrating
A study by Yang et al., 2024, demonstrated a negative correlation between the onset of T2D and adherence to a prudent diet, characterized by high intake of whole grains, fruits, fish, and vegetables
We did not evaluate small-study effect bias with a funnel plot due to the small number of included trials [16]